Trial
NCT01988077
Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for Metastatic Melanoma Patients
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Sheba Medical Center
Collaborators
—
Condition
A Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of Response
Intervention
Adoptive cell transfer
Why stopped
due to toxicity of cyclophosphamide
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-05